Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection

Annals of Internal Medicine

Volumn 159, Issue 5, 2013, Pages 372-

  Chou, Roger ^a   Wasson, Ngoc ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TESTIS BARRIER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 85047689121     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-159-5-201309030-00021     Document Type: Letter

References (5)

1. Poynard T, Ngo Y, Perazzo H, Munteanu M, Lebray P, Moussalli J, et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (N Y). 2011;7:445-54. [PMID: 22298979]
2. Takwoingi Y, Leeflang MM, Deeks JJ. Empirical evidence of the importance of comparative studies of diagnostic test accuracy. Ann Intern Med. 2013;158:544-54. [PMID: 23546566]
3. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 2006;52:1887-96. [PMID: 16931569]
4. Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140:1970-9, 1979. e1-3. [PMID: 21376047]
5. Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, et al; multicentric groups (SNIFF 14 & 17, ANRS HC EP 23 Fibrostar). Optimization and robustness of blood tests for liver fibrosis and cirrhosis. Clin Biochem. 2010;43:1315-22. [PMID: 20713037]